Dna X (SONM) Operating Margin (2018 - 2025)
Historic Operating Margin for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to 24.55%.
- Dna X's Operating Margin fell 87300.0% to 24.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 54.43%, marking a year-over-year decrease of 318900.0%. This contributed to the annual value of 57.7% for FY2024, which is 582500.0% down from last year.
- According to the latest figures from Q3 2025, Dna X's Operating Margin is 24.55%, which was down 87300.0% from 60.16% recorded in Q2 2025.
- In the past 5 years, Dna X's Operating Margin ranged from a high of 3.86% in Q1 2025 and a low of 147.52% during Q4 2024
- Over the past 5 years, Dna X's median Operating Margin value was 24.55% (recorded in 2025), while the average stood at 36.73%.
- Its Operating Margin has fluctuated over the past 5 years, first soared by 693100bps in 2022, then crashed by -1381700bps in 2024.
- Over the past 5 years, Dna X's Operating Margin (Quarter) stood at 73.71% in 2021, then skyrocketed by 94bps to 4.39% in 2022, then crashed by -113bps to 9.34% in 2023, then plummeted by -1479bps to 147.52% in 2024, then skyrocketed by 83bps to 24.55% in 2025.
- Its Operating Margin was 24.55% in Q3 2025, compared to 60.16% in Q2 2025 and 3.86% in Q1 2025.